NYSE · CON
Healthcare · Medical - Equipment & Services
$34.47
Down-$0.04 (-0.12%)
Updated Sep 5, 2026, 6:56 PM
SID Score
7.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
CON closed at $34.47 after 21 trading sessions, up 1.20% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $34.24 | $34.75 | $34.225 | $34.47 | 363.45K |
| Sep 3, 2026 | $34.30 | $34.60 | $33.753 | $34.51 | 841.96K |
| Sep 2, 2026 | $34.07 | $34.60 | $34.00 | $34.03 | 658.44K |
| Sep 1, 2026 | $33.98 | $34.34 | $33.805 | $33.89 | 587.2K |
| Aug 31, 2026 | $34.33 | $34.33 | $33.62 | $33.74 | 838.95K |
| Aug 28, 2026 | $34.92 | $34.92 | $34.192 | $34.26 | 508.13K |
| Aug 27, 2026 | $34.62 | $34.92 | $34.43 | $34.70 | 561.64K |
| Aug 26, 2026 | $34.95 | $35.31 | $34.62 | $34.95 | 683.96K |
| Aug 25, 2026 | $35.26 | $35.315 | $34.55 | $34.78 | 632.3K |
| Aug 24, 2026 | $34.58 | $35.4754 | $34.58 | $34.99 | 581.35K |
| Aug 21, 2026 | $34.96 | $35.16 | $34.655 | $35.00 | 844.29K |
| Aug 20, 2026 | $35.49 | $35.49 | $34.45 | $34.81 | 616.49K |
| Aug 19, 2026 | $35.34 | $35.675 | $34.56 | $34.77 | 964.11K |
| Aug 18, 2026 | $35.47 | $35.90 | $35.04 | $35.05 | 894.89K |
| Aug 17, 2026 | $35.54 | $35.8315 | $35.051 | $35.53 | 758.86K |
| Aug 14, 2026 | $34.91 | $35.52 | $34.90 | $35.43 | 811.53K |
| Aug 13, 2026 | $35.00 | $35.135 | $34.55 | $35.12 | 1.66M |
| Aug 12, 2026 | $32.74 | $34.55 | $32.74 | $34.54 | 1.34M |
| Aug 11, 2026 | $34.36 | $34.38 | $33.00 | $33.03 | 796.54K |
| Aug 10, 2026 | $33.56 | $34.7526 | $33.325 | $34.10 | 982.23K |
| Aug 7, 2026 | $34.27 | $35.15 | $32.09 | $34.06 | 2.04M |
The latest Smart Investors Daily articles mentioning CON.
CON research
Company profile and research snapshot.
Concentra Group Holdings Parent Inc is a provider of occupational health services in the United States. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2026 | Wells Fargo | Overweight | — |
| Aug 10, 2026 | RBC Capital | Outperform | — |
| Aug 10, 2026 | Truist Securities | Buy | — |
| Jul 14, 2026 | Truist Securities | Buy | — |
| Jul 1, 2026 | William Blair | Outperform | — |
No generated briefing is available yet.
Benzinga · Mar 5, 2026
Wells Fargo analyst Stephen Baxter maintains Concentra Group Holdings (NYSE:CON) with a Overweight and raises the price target from $25 to $28.
SeekingAlpha · Feb 27, 2026
SeekingAlpha · Feb 27, 2026
ChartMill · Feb 26, 2026
Concentra (CON) beats Q4 earnings and revenue estimates with strong patient volume and strategic clinic expansion, while issuing confident 2026 guidance.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CON.
